RNA Research Solutions
-
R1011 EZ Cap™ Cy5 EGFP mRNA (5-moUTP)26 CitationSummary: EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation -
R3002 Firefly Luciferase saRNASummary: Self-Amplifying RNA expressing firefly luciferase (Fluc mRNA) -
R2002 Firefly Luciferase circRNASummary: Circular RNA expressing firefly luciferase (Fluc mRNA) -
B8332 Fluorescein-12-UTPSummary: Fluorescein-labeled UTP for RNA labeling -
R1013 EZ Cap™ Firefly Luciferase mRNA (5-moUTP)34 CitationSummary: Firefly Luciferase mRNA (Fluc mRNA) with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
K1046 RNase Inhibitor, Murine29 CitationSummary: Murine RNase Inhibitor -
M2001 DMG-PEG 20001 CitationSummary: PEG modified phospholipids for liposome delivery -
R1047 EZ Cap™ mCherry mRNA (m1Ψ)1 CitationSummary: mCherry mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
B7967 5-Methyl-CTP8 CitationSummary: 5-Methyl modified cytidine triphosphate for in vitro transcription synthesis of mRNA -
R1010 EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)36 CitationSummary: Firefly Luciferase mRNA (Fluc mRNA) with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation